Japan, June 16 -- ASTRAZENECA AB has got intellectual property rights for 'PCSK9 INHIBITORS AND METHODS OF USE THEREOF.' Other related details are as follows:
Application Number: JP,2024-208167
Category (FI): A61K31/404,A61K31/47,A61K31/22,A61K31/505,C07D491/107,C07D487/04,145,C07D471/10,101,A61K31/444,C07D413/14,C07D487/04,140,C07D495/04,105,C07D491/056,C07D471/10,C07D471/04,113,A61K31/5383,C07D498/04,111,C07D487/04,144,A61K31/519,C07D471/04,116,C07D471/04,107@Z,C07D498/10,A61K31/5386,C07D487/04,142,C07D403/14,C07D401/14,C07D401/12,C07D413/12,C07D403/12,A61K31/517,C07D498/04,101,C07D487/10,C07D491/20,A61K31/5377,A61K31/496,A61K31/541,C07D417/14,A61K31/506,C07D417/12,A61P9/00,A61P3/06,A61P9/10,A61P1/16,A61P3/00,A61P43/00,121,A61K45/00,A61K31/40,A61K31/4418,A61K31/366
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Nov. 29, 2024
Publication Date: March 26, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
